Anidulafungin improves outcome at no extra cost

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.633, 2011-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anidulafungin cost effective for candidaemia and candidiasis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 580, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Anidulafungin

By David Murdoch Greg L. Plosker

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2249-2258

Adis International

Access to resources Recommend Favorite

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients

By Reboli Annette C.

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 705-717

Adis International

Access to resources Recommend Favorite

Guideline adherence improves stroke outcome

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Deferasirox improves outcomes at acceptable cost

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite